Teyi Pharmaceutical: Announcement on the progress of share repurchases
Teyi Pharmaceutical: Announcement on the early return of funds raised from non-public temporary supplementary working capital
Teyi Pharmaceutical: Announcement on the progress of share repurchases
Teyi Pharmaceutical: Announcement on the progress of share repurchases
Teyi Pharmaceutical Group: Announcement about the progress of stock repurchase.
Teyi Pharmaceutical Group: Announcement on the Progress of Repurchasing Company Shares to Reach 2% Proportion
Teyi Pharmaceutical Group: Announcement on the progress of repurchasing the company's shares to reach 1% of the proportion.
Teyi Pharmaceutical Group: Announcement about the progress of stock repurchase.
Teyi Pharmaceutical Group: Announcement Regarding the Company's First Share Repurchase
Teyi Pharmaceutical Group: Announcement regarding the early return of the temporarily supplementary working capital raised from non-public offering.
Teyi Pharmaceutical Group: Buyback Share Report
Teyi Pharmaceutical Group: Announcement regarding the proposal of the controlling shareholder, actual controller, and chairman to repurchase company shares.
Teyi Pharmaceutical Group: Announcement regarding the share repurchase plan of the company.
Teyi Pharmaceutical: Notice on the early return of funds raised from the non-public offering to temporarily supplement working capital
Teyi Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Teyi Pharmaceutical: An indicative announcement on the listing and circulation of restricted shares to specific targets through a simplified procedure in 2023
Teyi Pharmaceutical: Announcement on the completion of cancellation of some stock options in the 2021 Stock Options Incentive Plan
Teyi Pharmaceutical: Notice on the early return of funds raised from the non-public offering to temporarily supplement working capital
Teyi Pharmaceutical: Announcement on Adjusting the Number of Stock Options and Exercise Prices of the 2021 Stock Options Incentive Plan
Teyi Pharmaceutical: Legal Opinion on Cancelling Some Stock Options and Adjusting the Number and Exercise Price of Stock Options in the 2021 Stock Option Incentive Plan
No Data
No Data